NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-013-2012-0-US-04 Gene Expression Signatures of Neoplasm Responsiveness to Therapy US National Stage 14/357,191 9670549 Issued PDF
NCATS E-234-2012-0-ZA-27 PAK Inhibitors For the Treatment of Fragile X Syndrome ZA National Stage 2014/03290 Pending
NCATS E-234-2012-0-DZ-10 PAK Inhibitors For the Treatment of Fragile X Syndrome DZ National Stage 2063-02-14 Pending
NINDS E-301-2007-0-JP-15 Summation Of TMS Stimulation Through Several Coils JP DIV 2014-096324 Issued
NCATS E-234-2012-0-NZ-21 PAK Inhibitors For the Treatment of Fragile X Syndrome NZ National Stage 624637 Abandoned
NCI E-156-2014-1-US-01 Triggering RNA Interference With RNA, RNA-DNA And DNA-RNA Nanoparticles US 61/990,094 Abandoned
NINDS E-122-2014-0-US-01 Systems and Methods for a Current Amplifier For Local Coil Pre-amplification Of NMR/MRI Signals US 61/989,795 Abandoned
NCI E-207-2008-0-US-04 Dual Specific Immunotoxin for Brain Tumor Therapy US CON 14/270,836 9492564 Issued PDF
NIAID E-253-2011-3-US-05 Neutralizing GP41 Antibodies And Their Use US National Stage 14/356,557 9475862 Issued PDF
NCI E-156-2014-0-US-01 Triggering RNA Interference With RNA-DNA And DNA-RNA Nanoparticles US 61/989,520 Abandoned
NICHD E-308-2008-0-US-04 Vaccine For Shigella US DIV 14/270,220 9144604 Abandoned PDF
NHGRI E-039-2014-1-US-01 Compounds and Method for Treating PARP1-Deficient Cancers US 61/988,502 Abandoned
NCATS E-234-2012-0-EG-12 PAK Inhibitors For the Treatment of Fragile X Syndrome EG National Stage PCT 720/2014 Pending
NCI E-196-2000-0-US-08 Defensin-Antigen Fusion Proteins US DIV 14/268,949 Abandoned
NCATS E-234-2012-0-US-28 Preparation Of Pyrido[2,3-d]pyrimidines As Group 1 PAK Inhibitors US National Stage 14/356,118 Abandoned
NCI E-003-2008-0-US-06 Methods of Obtaining Antigen-Specific T Cell Populations US DIV 14/268,147 Abandoned
NCATS E-234-2012-0-BR-04 PAK Inhibitors For the Treatment of Fragile X Syndrome BR National Stage BR112014010631-2 Pending
NCATS E-234-2012-0-JP-16 PAK Inhibitors For the Treatment of Fragile X Syndrome JP National Stage 2014-540157 Pending
NIDCR E-289-2015-0-US-01 Combinatorial Cassette For High-Throughput In Vivo Screening Of Osteogenesis US 61/987,591 Abandoned
NCI E-118-2013-0-PCT-02 Mesothelin-Specific Immunocytokine And Use Thereof PCT PCT PCT/US2014/036296 Expired
NIAID E-299-2011-0-US-03 Use Of Peptide-manganous Complexes To Protect Microorganisms And Cells From Radiation Damage During Creation Of Lethally Irradiated Vaccines US National Stage 14/355,063 Abandoned
NIBIB E-079-2011-1-US-02 Imaging Agents for Imaging Protease Activity and Uses Thereof US National Stage 14/343,469 Pending
NCATS E-757-2013-1-US-01 USE OF 12-LIPOXYGENASE INHIBITORS FOR INHIBITION OF PLATELET ACTIVATION AND TREATMENT OF THROMBOSIS US 61/987,129 Abandoned
NIDA E-128-2006-0-US-05 4-Phenylpiperazine Derivatives With Functionalized Linkers As Dopamine D3 Receptor Selective Ligands And Methods of Use US DIV 14/266,076 Abandoned
NCATS E-234-2012-0-CL-05 PAK Inhibitors For the Treatment of Fragile X Syndrome CL National Stage 2014-1132 Pending
NCATS E-234-2012-0-MX-19 PAK Inhibitors For the Treatment of Fragile X Syndrome MX National Stage MX/a/2014/005296 Pending
NCI E-193-2014-0-US-01 Design, Synthesis, And Biological Evaluation Of O-2-Modified Indenoisoquinolines As Dual Topoisomerase I (Top1)-Tyrosyl-DNA Phosphodiesterase I (TDP1) Inhibitors US 61/985,748 Abandoned
NCI E-015-2013-0-PCT-02 Novel Peptide Hydrogels Generating Chemical Exchange Saturation Transfer MRI Contrast And Uses Thereof PCT PCT PCT/US2014/035651 Expired
NIAID E-109-2007-1-US-11 Detection Of Infectious Prion Protein By Seeded Conversion Of Recombinant Prion Protein US CON 14/263,703 Abandoned
NCI E-224-2011-0-US-05 Method of Treating HCV Infection With a Small Molecule CHK2 Inhibitor US National Stage 14/353,976 9278089 Abandoned PDF
NINDS E-206-2011-3-US-02 USE OF PHOSPHATASE INHIBITORS OR HISTONE DEACETYLASE INHIBITORS TO TREAT DISEASES CHARACTERIZED BY LOSS OF PROTEIN FUNCTION US National Stage 14/119,849 Abandoned
NHLBI E-186-2014-0-US-01 SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 US 61/983,973 Abandoned
NIA E-172-2009-0-US-08 Methods For Enhancing Genome Stability And Telomere Elongation In Embrionic Stem Cells US CON 14/259,600 9012223 Issued PDF
NIMH E-225-2011-1-US-02 Beta-amyloid PET Imaging Agents, Methods Of Manufacture, And Methods Of Use Thereof US National Stage 14/345,004 Abandoned
NCI E-018-1999-1-US-04 Molecular Motor US DIV 14/260,099 Abandoned
NCI E-266-2011-0-US-07 T Cell Receptors Recognizing HLA-A1- or HLA-CW7-Restricted Mage US National Stage 14/344,354 Abandoned
NEI E-046-2012-0-PCT-02 Oral Tolerance And The Treatment Of Age Related Macular Degeneration (AMD) PCT PCT PCT/US14/034948 Expired
NCATS E-234-2012-0-IL-15 PAK Inhibitors For the Treatment of Fragile X Syndrome IL National Stage 232154 Pending
NIA E-012-2012-0-KR-07 Combined IVIG And C1 Inhibitor Therapy For Neurological Disorders KR National Stage 10-2014-7010605 Issued
NCI E-771-2013-2-US-01 Modified Pseudomonas Exotoxin A US 61/982,051 Abandoned
NCI E-265-2011-0-JP-09 Anti-CD22 Chimeric Antigen Receptors JP National Stage 2014-537287 Abandoned
NCI E-265-2011-0-CN-06 Anti-CD22 Chimeric Antigen Receptors CN National Stage 201280051365.6 Issued
NCI E-265-2011-0-US-11 Anti-CD22 Chimeric Antigen Receptors US National Stage 14/352,530 9868774 Issued PDF
NCI E-265-2011-0-ES-19 Anti-CD22 Chimeric Antigen Receptors ES EP 12781544.7 Abandoned
NCI E-265-2011-0-LI-21 Anti-CD22 Chimeric Antigen Receptors LI EP 12781544.7 Abandoned
NCI E-265-2011-0-NL-22 Anti-CD22 Chimeric Antigen Receptors NL EP 12781544.7 Abandoned
NCI E-265-2011-0-IT-20 Anti-CD22 Chimeric Antigen Receptors IT EP 12781544.7 Abandoned
NCI E-265-2011-0-DE-15 Anti-CD22 Chimeric Antigen Receptors DE EP 12781544.7 Abandoned
NCI E-265-2011-0-FR-16 Anti-CD22 Chimeric Antigen Receptors FR EP 12781544.7 Abandoned
NCI E-265-2011-0-GB-17 Anti-CD22 Chimeric Antigen Receptors GB EP 12781544.7 Abandoned